Why is the GIST supply chain more complex than standard oncology?

GIST therapies are almost exclusively oral TKIs, which means the supply chain relies heavily on specialty pharmacies rather than hospital infusion centers. This "home-delivery" model requires a high level of coordination between manufacturers, PBMs (Pharmacy Benefit Managers), and patients to ensure there are no gaps in therapy.

How is GIST Specialty Pharmacy Integration evolving in 2024?

The 2024 trend is toward GIST Specialty Pharmacy Integration where the pharmacy provides more than just the drug. They are now offering integrated clinical counseling and side-effect management. For procurement teams, choosing the right specialty pharmacy partner is critical for ensuring that high-cost medications are used correctly, minimizing "waste" from patient non-compliance.

What is the impact of "White Bagging" in 2025?

Looking at 2025, the practice of "white bagging"—where the payer mandates that the drug be shipped directly to the patient or clinic by a preferred specialty pharmacy—will continue to grow. This shifts the financial control away from hospitals and toward insurers, forcing manufacturers to build stronger direct relationships with these third-party distributors.

2025 Logistics Outlook

The 2025 outlook for GIST logistics is defined by "Real-Time Tracking." Manufacturers will utilize IoT-enabled packaging to monitor not just the location of the drug, but also temperature and humidity, ensuring that the efficacy of these sensitive molecular compounds is preserved from factory to front door.

Author: Sofiya Sanjay

Designation: Healthcare Research Consultant, Market Research Future

About: At Market Research Future (MRFR), we enable organizations to unravel complex industries through Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Our studies across products, technologies, applications, end users, and global to country-level segments help decision-makers see more, know more, and do more.

Contact: 99 Hudson Street, 5th Floor, New York, NY 10013, USA | (855) 661-4441 (US) | +44 1720 412 167 (UK) | +91 2269738890 (APAC) | info@marketresearchfuture.com